SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: blankmind who wrote (4470)1/15/1998 2:33:00 PM
From: Tunica Albuginea  Read Replies (1) of 23519
 
Blankmind, in regards to Barons/Goldstein and your letter.I think that Goldstein's assertions have already been answered by the over 100 Urologists who have published the MUSE studies on effectiveness.
The fact that Barrons reporter does not wish to acknowledge this
is testimony to me that there is something fishy going on, what with the big short interest and selective Barrons reporting on Vivus
plus turn abouts by Padma N, etc. Time will tell.
By the way Goldstein's lab in Boston is not the only one in the nation and there is fine work done in numerous other places.Barrons just wants to keep beating the same old drum.
The down side on Vivus is actually 8 IMO, going back to 1995.
I am sorprised that 1st call has Vivus down for $1.04 in 97 and 0.98 in 1998 !!! : they must not be reading this thread, gg.

TA

TA
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext